Key references: Approach to testosterone replacement therapy

  • Cunningham GR, Toma SM. Clinical review: Why is androgen replacement in males controversial? J Clin Endocrinol Metab 2011;96(1):38–52. https://www.ncbi.nlm.nih.gov/pubmed/20881265
  • Grossmann M, Matsumoto AM. A perspective on middle-aged and older men with functional hypogonadism: focus on holistic management. J Clin Endocrinol Metab 2017;102(3):1067–75. https://www.ncbi.nlm.nih.gov/pubmed/28359097
  • Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, et al. Effects of testosterone treatment in older men. N Engl J Med 2016;374(7):611–24. https://www.ncbi.nlm.nih.gov/pubmed/26886521
  • Yeap BB, Page ST, Grossmann M. Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials. Lancet Diabetes Endocrinol 2018;6(8):659–72. https://www.ncbi.nlm.nih.gov/pubmed/30017800
  • Yeap BB, Grossmann M, McLachlan RI, Handelsman DJ, Wittert GA, Conway AJ, et al. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Med J Aust 2016;205(5):228–31. https://www.ncbi.nlm.nih.gov/pubmed/27581270